GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 169   

Articles published

GSK 47.20 +0.18 (0.38%)
price chart
GlaxoSmithKline plc (ADR) Wins Green Signal From UK Government For ...
The British pharmaceutical giant GlaxoSmithKline Plc (ADR) (NYSE:GSK) has finally reached an agreement with the UK government to provide its meningitis B vaccine as a mass program.
GlaxoSmithKline plc (ADR) And NewLink Genetics Corp, Ebola Vaccines Clear ...
The US National Institutes of Health (NIH) said that two experimental Ebola vaccines, one from GlaxoSmithKline plc (ADR) (NYSE:GSK) and another from NewLink Genetics Corp (NASDAQ:NLNK), ´┐Żappear to be safe,´┐Ż as per the initial data review of mid-stage ...
GlaxoSmithKline plc (ADR) Fires Over 100 Employees In China Over Bribery Case
GlaxoSmithKline Plc (ADR) (NYSE:GSK) has reportedly fired 110 of its employees in China. The move is a result of the extensive investigation that was conducted to inspect the corruption and bribery scandal, for which the drug maker was fined $479 ...
GlaxoSmithKline plc (ADR) And Novartis AG (ADR) Complete Three-Part Deal ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) and Novartis AG (ADR) (NYSE:NVS) announced on Monday that the two companies have completed a series of complicated asset swaps worth $20 billion, in what appears to be a move to tidy up asset portfolios to ...
Asset Swaps Of Novartis AG (ADR) (NYSE:NVS) and GlaxoSmithKline plc (ADR ...  Stocks.org
GlaxoSmithKline plc (ADR) (NYSE:GSK) CEO Andrew Witty's Pay Cut By 46%  InvestCorrectly
GlaxoSmithKline plc (ADR) Lays Off 180 More Workers In North Carolina
British pharmaceutical giant GlaxoSmithKline Plc (ADR) (NYSE:GSK) announced Monday another round of layoffs at its Research Triangle Park Campus in North Carolina.
GlaxoSmithKline plc (ADR) Interested In Wrapping Up Negotiations Over ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) is gearing up to finalize negotiations with the UK Department of Health regarding the pricing of its meningitis B vaccine, in order to have it distributed in Britain.
GlaxoSmithKline plc (ADR) Asthma Drug Wins Green Signal From FDA Panel ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) and Theravance Inc's (NASDAQ:THRX) respiratory medication Breo Ellipta for chronic obstructive pulmonary disease (COPD) won backing of a US Food and Drug Administration (FDA) advisory panel on Thursday, ...
Critical inspection of GlaxoSmithKline plc (ADR) (NYSE:GSK) by FDA ...  WallStreet.org
GlaxoSmithKline plc (ADR), Merck & Co., Inc., Pfizer Inc., Sanofi SA (ADR ...
Home > GlaxoSmithKline plc (ADR), Merck & Co., Inc., Pfizer Inc., Sanofi SA (ADR): Are Big Pharma Stocks In Trouble?
GlaxoSmithKline plc (ADR) Respiratory Drug Breo Faces FDA Scrutiny Over ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) and Theravance Inc's (NASDAQ:THRX) respiratory medication for chronic obstructive pulmonary disease (COPD), Breo Ellipta, failed to show any safety concerns when used to treat asthma, as per a preliminary review ...
GlaxoSmithKline plc (ADR) Attains $853 Million; To Sell Half Its Stake In ...
British pharmaceutical giant GlaxoSmithKline Plc has completed the sale of half its stake in South African drug maker Aspen Pharmacare HLD (OTCMKTS:APNHF), raising a hefty amount of $853.39 million as a result.